1.
Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by blue light in the treatment of facial cutaneous squamous cell carcinoma in situ. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 19];8(6):s483. Available from: https://skin.dermsquared.com/skin/article/view/3033